We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 8
Most popular |Most recent


The Importance of Properly Maintaining Priority

USA - October 11 2018 On October 1, 2018, the Federal Circuit issued an opinion, Natural Alternatives International, Inc. v. Iancu, concerning priority claims in familial...

Darren S. Mogil.


Nobel Biocare Services AG v. Instradent USA, Inc

USA - October 3 2018 On September 13, 2018, the Federal Circuit affirmed the final written decision of the Patent Trial and Appeal Board in an inter partes review filed by...

Darren S. Mogil.


FDA’S Clarification of 180-Day Exclusivity Rules

USA - August 23 2018 On July 13, 2018, the FDA issued a letter to ANDA applicants for buprenorphine and naloxone sublingual film that has application beyond that drug...

Marilyn Neiman.


Sham Litigation in a Hatch-Waxman Action

USA - July 10 2018 The largest award in a litigated FTC antitrust case was just issued. It is a warning to brand pharma to take their Hatch-Waxman case filings seriously...

Marilyn Neiman.


Attorney-Client Privilege Can Protect Multi-Purpose Corporate Communications

USA - July 5 2018 A question that has vexed corporate litigants is whether communications between counsel (be it in-house or outside counsel) and a corporation’s...

Darren S. Mogil.